Skip to content
SCNIScinai Immunotherapeutics Ltd.

SCNI holders

Who holds Scinai Immunotherapeutics Ltd., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.

Moves this quarter

Among the largest holders, against their report a quarter earlier.
Managers
6
Shares held
53.7K
Value held
$31.4K
Opened
2
Closed
6

Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.

ManagerSharesChangeValueOf portfolioFiled
Citadel Advisors LLC20.8K−66.7%$29.5K0%Nov 16, 2026
Rhumbline Advisers1.3K−90.0%$1.9K0%Nov 10, 2026
HRT Financial LP31.6K+161.6%$440.1%Nov 13, 2026
Morgan Stanley5−91.4%$70%Nov 13, 2026
JPMorgan Chase & Co2New$30%Nov 12, 2026
Danske Bank A/S1New$10%Nov 9, 2026